Cargando…
Modulation of CRTh2 expression on allergen‐specific T cells following peptide immunotherapy
BACKGROUND: Allergen immunotherapy using synthetic peptide T‐cell epitopes (Cat‐PAD) from the major cat allergen Fel d 1 has been shown, in allergen exposure studies, to significantly reduce symptoms of allergic rhinoconjunctivitis in cat‐allergic subjects. However, the immunological mechanisms unde...
Autores principales: | Rudulier, Christopher D., Tonti, Elena, James, Eddie, Kwok, William W., Larché, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817377/ https://www.ncbi.nlm.nih.gov/pubmed/31077596 http://dx.doi.org/10.1111/all.13867 |
Ejemplares similares
-
Immunotherapy with Allergen Peptides
por: Larché, Mark
Publicado: (2007) -
Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy
por: Mitthamsiri, Wat, et al.
Publicado: (2018) -
124 Heterogeneity of Allergen Epitope-specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-based Immunotherapy
por: Wambre, Erik, et al.
Publicado: (2012) -
Allergen Peptides, Recombinant Allergens and Hypoallergens for Allergen-Specific Immunotherapy
por: Marth, Katharina, et al.
Publicado: (2014) -
97 Grass Pollen Allergen-induced Surface Expression of CD203C, CD63 and CD107A on CRTH2+ Basophils: Novel Biomarkers for Monitoring Efficacy of Allergen-specific Immunotherapy
por: Shamji, Mohamed, et al.
Publicado: (2012)